LABTRACE.ORG BETA LIVE
246 source polls this hour 49 929 articles collected last article 16m ago 834 events on 2+ sources 0 embeddings/h feed queue 0 lag 263.7s
← health
LT-003306 / first seen 2026-08-05 18:37 / last activity 51d ago solid / under-covered

Landmark ctDNA molecular response represents an early predictor of immunotherapy outcomes in lung cancer: A clinical validity study

measurement

heat
1 / 100 (raw 0.0)
velocity
0.0 independent sources per hour
solidity
80 / 100
sources
1 total, 1 independent
domain span
1 domain covered it

primary source

title
Landmark ctDNA molecular response represents an early predictor of immunotherapy outcomes in lung cancer: A clinical validity study
venue
status
peer-reviewed
doi
10.1158/1078-0432.ccr-26-0656
published
2026-07-23

media coverage / 1 outlets